* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jacobio Pharmaceuticals Group Co Days Payable Chart
JBPHF vs VRTX, REGN, ALNY: Days Payable Comparison
For the Biotechnology subindustry, Jacobio Pharmaceuticals Group Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jacobio Pharmaceuticals Group Co Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Jacobio Pharmaceuticals Group Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Jacobio Pharmaceuticals Group Co's Days Payable falls into.
Jacobio Pharmaceuticals Group Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jacobio Pharmaceuticals Group Co (JBPHF) has a Days Payable of 16,751.98 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Jacobio Pharmaceuticals Group Co and its competitors. This is 4902% above median its historical median of 334.92. Over the past decade, Jacobio Pharmaceuticals Group Co's Days Payable has ranged from 102.25 to 48,486.49. According to the industry distribution chart, Jacobio Pharmaceuticals Group Co ranks #16 out of 707 companies in the Biotechnology industry, placing it in the top 2.3%.
Is Jacobio Pharmaceuticals Group Co's Days Payable too high?
Jacobio Pharmaceuticals Group Co's current Days Payable of 16,751.98 is 4902% above median its 10-year median of 334.92. Over the past 10 years, this metric has ranged from a low of 102.25 to a high of 48,486.49. The Biotechnology industry median Days Payable is 113.76. Jacobio Pharmaceuticals Group Co's value of 16,751.98 is 14625.7% above this industry median. Based on the distribution chart, Jacobio Pharmaceuticals Group Co ranks #16 out of 707 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Jacobio Pharmaceuticals Group Co has a GF Score™ of 54/100, reflecting its overall financial health beyond just this single metric.
How does Jacobio Pharmaceuticals Group Co's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Jacobio Pharmaceuticals Group Co ranks #16 out of 707 companies for Days Payable. This places Jacobio Pharmaceuticals Group Co in the top 2% of its industry — outperforming the majority of peers. The industry median Days Payable is 113.76. Jacobio Pharmaceuticals Group Co's value of 16,751.98 is 14625.7% above this benchmark. Historically, Jacobio Pharmaceuticals Group Co's own Days Payable has ranged from 102.25 to 48,486.49 over the past decade. While the company's 10-year median is 334.92 vs. the industry median of 113.76, Jacobio Pharmaceuticals Group Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.76, based on 707 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jacobio Pharmaceuticals Group Co's current Days Payable of 16,751.98 is 14625.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Jacobio Pharmaceuticals Group Co and its competitors. For the Biotechnology industry, the median Days Payable is 113.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jacobio Pharmaceuticals Group Co's current Days Payable is 16,751.98, which is 4902% above median its own 10-year median of 334.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jacobio Pharmaceuticals Group Co stock overvalued right now?
Jacobio Pharmaceuticals Group Co (JBPHF) has a current Days Payable of 16,751.98. The stock's GF Value™ is $0.42, compared to a current price of $0.87 — trading 106.6% above its estimated fair value. The current Days Payable is 16,751.98, which is 4902% above median its 10-year median of 334.92 and 14625.7% above the Biotechnology industry median of 113.76. Jacobio Pharmaceuticals Group Co's overall GF Score™ is 54/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Jacobio Pharmaceuticals Group Co (JBPHF), the current Days Payable is 16,751.98 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jacobio Pharmaceuticals Group Co (JBPHF) Overvalued in 2026?
Based on GuruFocus' analysis, Jacobio Pharmaceuticals Group Co stock appears to be overvalued.
The current stock price of $0.87 is trading 106.6% above its estimated GF Value™ of $0.42.
Key valuation signals for JBPHF:
Days Payable: 16,751.98 (4902% above median its 10-year median of 334.92)
GF Value™: $0.42 vs. price of $0.87 (106.6% above fair value)
Industry Position: 14625.7% above the Biotechnology median (#16 of 707)
No single metric tells the full story. See the JBPHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jacobio Pharmaceuticals Group Co Business Description
Jacobio Pharmaceuticals Group Co Ltd is a clinical-stage pharmaceutical company focusing on the in-house discovery and development of oncology therapies. The company is engaged in developing breakthrough cancer therapies for patients. The producst pipeline of the company includes KRAS G12C inhibitor, SHP2 inhibitor, Pan-KRAS inhibitor, KRAS G12D ADC JAB-BX600, Aurora Kinase A (AURKA) inhibitor, BET inhibitor, P53 Y220C mutant proteins, and others.
54GF Score
Get the complete analysis for JBPHF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JBPHF has been successfully added to your 
